Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.05 per share
-
Shares outstanding
-
95,490,450
-
Total 13F shares
-
13,435,563
-
Share change
-
+679,772
-
Total reported value
-
$209,551,644
-
Put/Call ratio
-
91%
-
Price per share
-
$15.60
-
Number of holders
-
66
-
Value change
-
+$8,545,734
-
Number of buys
-
34
-
Number of sells
-
27
Institutional Holders of Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) as of Q2 2019
As of 30 Jun 2019,
Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) was held by
66 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,435,563 shares.
The largest 10 holders included
FMR LLC, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., ARK Investment Management LLC, Capital World Investors, ARMISTICE CAPITAL, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., MORGAN STANLEY, CREDIT SUISSE AG/, and Capital International Investors.
This page lists
66
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.